Finance

Beta
Lists
WINT:OTCMKTS
Windtree Therapeutics Inc
$0.014
-5.40%
(-0.00082) 1D
Jun 4, 12:44:41 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WINT...
Open
$0.02
High
$0.02
Low
$0.01
Mkt. cap
363.55K
Avg. vol.
178.03K
Volume
32.72K
52-wk high
$1.86
52-wk low
$0.01
EPS
-$8.38
Beta
1.62
Shares outstanding
33.71M
No. of employees
14
Open
$0.02
High
$0.02
Low
$0.01
Mkt. cap
363.55K
Avg. vol.
178.03K
Volume
32.72K
52-wk high
$1.86
52-wk low
$0.01
EPS
-$8.38
Beta
1.62
Shares outstanding
33.71M
No. of employees
14
News stories
From sources across the web
Profile
Windtree Therapeutics, Inc. is an American company which was set up in 1992 and now is based in Warrington, Pennsylvania, developing drug products for patients with respiratory disease. The company joined an alliance with Laboratorios del Dr. Esteve, S.A. In 2016, Discovery Laboratories changed name to Windtree Therapeutics, Inc. Wikipedia
About Windtree Therapeutics Inc
CEO-
Employees14
FoundedNov 6, 1992
HeadquartersWarrington Township, Pennsylvania, United States
SectorBiotechnology
Websitewindtreetx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.19M
2.27M
2.18M
1.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.73M
1.82M
1.80M
1.86M
Operating expense
3.92M
4.09M
3.98M
3.75M
Total operating expenses
3.92M
4.09M
3.98M
3.75M
Operating income
-3.92M
-4.09M
-3.98M
-3.75M
Other non operating income
8.64M
-20.00K
873.00K
2.70M
EBT including unusual items
2.69M
-4.04M
-10.63M
-31.52M
EBT excluding unusual items
4.46M
-4.02M
-10.70M
-15.39M
Income tax expense
-77.00K
-
-
-3.43M
Effective tax rate
-2.86%
-
-
10.89%
Other operating expenses
-
-
-
-
Net income
2.77M
-4.04M
-10.63M
-28.08M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
8.00K
7.00K
198.00K
758.00K
Interest expense
-61.00K
-20.00K
-7.39M
-15.29M
Net interest expenses
-53.00K
-13.00K
-7.19M
-14.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.90M
-4.07M
-3.97M
-3.39M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer